Outcomes and toxicity following high-dose radiation therapy in 15 fractions for non-small cell lung cancer

AHRT in 15 fractions can be safe and effective. Consideration for using AHRT with immunotherapy and sequential chemotherapy for improved out-of-radiation field and distant control is warranted.